Skip to main content
letter
. 2020 Oct 8;26(11):e134–e136. doi: 10.1093/ibd/izaa254

TABLE 1.

List of Questions Sent to Participating Centers Related to the Activity of Remote Screening Activity for COVID-19

No. Questions
1 How many IBD patients in active follow-up at your center have been contacted by phone or video call in order to identify suspected cases of COVID19?
2 How many patients reported the following symptoms or signs?
Fever
…Cough
…Dyspnea?
…Anosmia?
…Dysgeusia?
…Diarrhea?
3 How many patients resulted suspected for COVID19 and received indication to perform SARS-CoV-2 RT-PCR test?
4 How many suspected patients who received SARS-CoV-2 RT-PCR resulted positive?
5 How many of the identified positive patients were admitted to the hospital?
6 How many of the identified positive patients were admitted to ICU?
7 How many of the identified positive patients died?
8 How many patients defined as suspected (confirmed and not confirmed) were contacted again after 2 weeks or more from the initial contact?
9 How many patients recovered?
10 In how many patients with suspicious symptoms or signs the therapy was self-suspended?
11 In how many patients with suspicious symptoms or signs the therapy was modified by the contacting IBD specialist?